EP300 and Miyoshi myopathy: Mechanistic analyses have revealed that CBP/p300 directly activates IRF4 expression through H3K18 and H3K27 acetylation at its super-enhancer and transcription start site; therefore, inhibition of CBP/p300 induces MM cell death via the reduction of IRF4 expression85.